S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
The #1 Energy Stock to Buy (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
Profit From the Commercial Solar Boom? (Ad)
How to Find Penny Stocks to Invest and Trade
ONSemi Is Marching Higher On Great Results
Profit From the Commercial Solar Boom? (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
The #1 Energy Stock to Buy (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
Profit From the Commercial Solar Boom? (Ad)
How to Find Penny Stocks to Invest and Trade
ONSemi Is Marching Higher On Great Results
Profit From the Commercial Solar Boom? (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
The #1 Energy Stock to Buy (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
Profit From the Commercial Solar Boom? (Ad)
How to Find Penny Stocks to Invest and Trade
ONSemi Is Marching Higher On Great Results
Profit From the Commercial Solar Boom? (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
The #1 Energy Stock to Buy (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
Profit From the Commercial Solar Boom? (Ad)
How to Find Penny Stocks to Invest and Trade
ONSemi Is Marching Higher On Great Results
Profit From the Commercial Solar Boom? (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Can Cummins Power To A New High? 
NYSE:PBH

Prestige Consumer Healthcare - PBH Stock Forecast, Price & News

$60.82
-0.14 (-0.23%)
(As of 02/6/2023 12:00 AM ET)
Add
Compare
Today's Range
$60.22
$62.39
50-Day Range
$60.35
$67.05
52-Week Range
$48.51
$67.45
Volume
270,504 shs
Average Volume
289,877 shs
Market Capitalization
$3.02 billion
P/E Ratio
14.59
Dividend Yield
N/A
Price Target
$71.00

Prestige Consumer Healthcare MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
16.7% Upside
$71.00 Price Target
Short Interest
Bearish
2.22% of Float Sold Short
Dividend Strength
N/A
Sustainability
-2.35
Upright™ Environmental Score
News Sentiment
0.59mentions of Prestige Consumer Healthcare in the last 14 days
Based on 17 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
2.56%
From $4.29 to $4.40 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.94 out of 5 stars

Consumer Discretionary Sector

164th out of 267 stocks

Pharmaceutical Preparations Industry

259th out of 500 stocks

PBH stock logo

About Prestige Consumer Healthcare (NYSE:PBH) Stock

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.

Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

PBH Stock News Headlines

A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
Prestige Consumer Healthcare (NYSE:PBH) Stock Price Down 11.2%
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
See More Headlines
Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

PBH Company Calendar

Last Earnings
2/02/2023
Today
2/06/2023
Fiscal Year End
3/31/2023
Next Earnings (Estimated)
5/04/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Personal Products
CUSIP
74112D10
Employees
505
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$71.00
High Stock Price Forecast
$72.00
Low Stock Price Forecast
$70.00
Forecasted Upside/Downside
+16.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$205.38 million
Pretax Margin
24.04%

Debt

Sales & Book Value

Annual Sales
$1.09 billion
Cash Flow
$4.82 per share
Book Value
$31.43 per share

Miscellaneous

Free Float
48,893,000
Market Cap
$3.02 billion
Optionable
Optionable
Beta
0.60

Key Executives

  • Ronald M. LombardiRonald M. Lombardi
    Chairman, President & Chief Executive Officer
  • Jeff Zerillo
    Senior Vice President-Operations
  • Christine Sacco
    Chief Financial Officer
  • William C. P'Pool
    Secretary, Senior Vice President & General Counsel
  • Adel Mekhail
    Executive Vice President-Marketing & Sales













PBH Stock - Frequently Asked Questions

Should I buy or sell Prestige Consumer Healthcare stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PBH shares.
View PBH analyst ratings
or view top-rated stocks.

What is Prestige Consumer Healthcare's stock price forecast for 2023?

5 analysts have issued 12-month target prices for Prestige Consumer Healthcare's stock. Their PBH share price forecasts range from $70.00 to $72.00. On average, they anticipate the company's share price to reach $71.00 in the next twelve months. This suggests a possible upside of 16.7% from the stock's current price.
View analysts price targets for PBH
or view top-rated stocks among Wall Street analysts.

How have PBH shares performed in 2023?

Prestige Consumer Healthcare's stock was trading at $62.60 at the beginning of the year. Since then, PBH shares have decreased by 2.8% and is now trading at $60.82.
View the best growth stocks for 2023 here
.

When is Prestige Consumer Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our PBH earnings forecast
.

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc. (NYSE:PBH) posted its quarterly earnings results on Thursday, February, 2nd. The company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.03. The firm had revenue of $275.50 million for the quarter, compared to analyst estimates of $273.84 million. Prestige Consumer Healthcare had a net margin of 18.97% and a trailing twelve-month return on equity of 12.65%. The company's revenue for the quarter was up .4% on a year-over-year basis. During the same period in the prior year, the business posted $0.99 EPS.

What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?

Prestige Consumer Healthcare updated its FY 2023 earnings guidance on Thursday, February, 2nd. The company provided earnings per share (EPS) guidance of $4.18-$4.18 for the period, compared to the consensus earnings per share estimate of $4.20. The company issued revenue guidance of $1.12 billion-$1.12 billion, compared to the consensus revenue estimate of $1.12 billion.

What is Ronald M. Lombardi's approval rating as Prestige Consumer Healthcare's CEO?

8 employees have rated Prestige Consumer Healthcare Chief Executive Officer Ronald M. Lombardi on Glassdoor.com. Ronald M. Lombardi has an approval rating of 61% among the company's employees. This puts Ronald M. Lombardi in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), AT&T (T), Intel (INTC), ONEOK (OKE), Wells Fargo & Company (WFC), International Business Machines (IBM), Micron Technology (MU) and Teva Pharmaceutical Industries (TEVA).

What is Prestige Consumer Healthcare's stock symbol?

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Who are Prestige Consumer Healthcare's major shareholders?

Prestige Consumer Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (2.14%), Rice Hall James & Associates LLC (1.26%), Leeward Investments LLC MA (1.09%), Fisher Asset Management LLC (0.82%), Burney Co. (0.60%) and Ziegler Capital Management LLC (0.44%). Insiders that own company stock include Mary Beth Fritz and Ronald M Lombardi.
View institutional ownership trends
.

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Prestige Consumer Healthcare's stock price today?

One share of PBH stock can currently be purchased for approximately $60.82.

How much money does Prestige Consumer Healthcare make?

Prestige Consumer Healthcare (NYSE:PBH) has a market capitalization of $3.02 billion and generates $1.09 billion in revenue each year. The company earns $205.38 million in net income (profit) each year or $4.17 on an earnings per share basis.

How many employees does Prestige Consumer Healthcare have?

The company employs 505 workers across the globe.

How can I contact Prestige Consumer Healthcare?

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The official website for the company is www.prestigebrands.com. The company can be reached via phone at (914) 524-6800, via email at irinquiries@prestigebrands.com, or via fax at 302-674-5266.

This page (NYSE:PBH) was last updated on 2/7/2023 by MarketBeat.com Staff